Xaar Valuation

Is XAR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of XAR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: XAR (€0.91) is trading below our estimate of fair value (€1.06)

Significantly Below Fair Value: XAR is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for XAR?

Key metric: As XAR is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for XAR. This is calculated by dividing XAR's market cap by their current revenue.
What is XAR's PS Ratio?
PS Ratio1x
SalesUK£64.74m
Market CapUK£62.45m

Price to Sales Ratio vs Peers

How does XAR's PS Ratio compare to its peers?

The above table shows the PS ratio for XAR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.9x
M3BK Pyramid
0.3x8.8%€21.5m
HYI Hyrican Informationssysteme
1xn/a€25.7m
C3RY Cherry
0.1x1.8%€14.9m
JY0 ParTec
6.3x36.6%€604.0m
XAR Xaar
1x11.0%€62.5m

Price-To-Sales vs Peers: XAR is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (1.9x).


Price to Sales Ratio vs Industry

How does XAR's PS Ratio compare vs other companies in the European Tech Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
XAR 1.0xIndustry Avg. 0.7xNo. of Companies8PS00.61.21.82.43+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: XAR is expensive based on its Price-To-Sales Ratio (1x) compared to the European Tech industry average (0.7x).


Price to Sales Ratio vs Fair Ratio

What is XAR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

XAR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: XAR is expensive based on its Price-To-Sales Ratio (1x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst XAR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.91
€2.26
+149.3%
10.7%€2.55€1.96n/a3
Nov ’25€1.00
€2.26
+125.6%
10.7%€2.55€1.96n/a3
Oct ’25€1.23
€2.26
+83.4%
10.7%€2.55€1.96n/a3
Sep ’25€1.24
€2.26
+81.9%
10.7%€2.55€1.96n/a3
Aug ’25€1.47
€2.26
+53.4%
10.7%€2.55€1.96n/a3
Jul ’25€1.70
€2.24
+31.6%
10.7%€2.53€1.94n/a3
Jun ’25€1.66
€2.21
+33.4%
10.7%€2.51€1.92n/a3
May ’25€1.31
€2.21
+69.0%
10.7%€2.51€1.92n/a3
Apr ’25€1.19
€2.21
+86.1%
10.7%€2.51€1.92n/a3
Mar ’25€1.16
€2.21
+90.4%
10.7%€2.50€1.92n/a3
Feb ’25€1.13
€2.21
+95.5%
10.7%€2.50€1.92n/a3
Jan ’25€1.25
€2.34
+87.3%
5.1%€2.50€2.21n/a3
Dec ’24€1.50
€2.57
+71.2%
9.6%€2.90€2.31n/a3
Nov ’24€1.84
€2.82
+53.1%
14.2%€3.27€2.30€1.003
Oct ’24€2.04
€3.11
+52.5%
6.3%€3.31€2.91€1.232
Sep ’24€2.12
€3.14
+47.9%
6.3%€3.33€2.94€1.242
Aug ’24€2.10
€3.14
+49.3%
6.3%€3.33€2.94€1.472
Jul ’24€1.92
€3.02
+57.1%
6.3%€3.21€2.83€1.702
Jun ’24€1.96
€3.02
+53.9%
6.3%€3.21€2.83€1.662
May ’24€1.89
€3.02
+59.6%
6.3%€3.21€2.83€1.312
Apr ’24€2.26
€3.02
+33.5%
6.3%€3.21€2.83€1.192
Mar ’24€1.88
€3.02
+60.5%
6.3%€3.21€2.83€1.162
Feb ’24€1.82
€3.02
+65.8%
6.3%€3.21€2.83€1.132
Jan ’24€2.14
€3.22
+50.5%
2.7%€3.31€3.13€1.252
Dec ’23€2.38
€3.22
+35.3%
2.7%€3.31€3.13€1.502
Nov ’23€1.90
€3.22
+69.5%
2.7%€3.31€3.13€1.842

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies